Showing posts with label lenalidomide. Show all posts
Showing posts with label lenalidomide. Show all posts
Monday, September 4, 2017

Study shows three-drug combination delays recurrence and lengthens life for myeloma patients

›
In continuation of my update on lenalidomide , bortezomib  and dexamethasone The International Myeloma Foundation (IMF) today announce...
Thursday, December 22, 2016

Maintenance lenalidomide treatment improves overall survival in multiple myeloma patients

›
In continuation of my update on  lenalidomide     lenalidomide   While several clinical trials have demonstrated that maintena...
Tuesday, July 30, 2013

Phase III study: REVLIMID meets primary endpoint in patients newly diagnosed with multiple myeloma

›
In continuation of my update on  lenalidomide Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ: C...
Saturday, December 8, 2012

Lenalidomide offers an effective alternative treatment for cutaneus lupus erythematosus, study suggests

›
In continuation of my update on  lenalidomide A new study into the thalidomide derivative lenalidomide,  shows that treatment with lena...
Saturday, August 11, 2012

Three-drug regimen provides rapid, durable responses for multiple myeloma

›
In continuation of my update on three drug combination A three-drug treatment for the blood cancer multiple myeloma provided rapid, d...
Friday, May 25, 2012

Lenalidomide Shows Significant Benefit for Myeloma Patients, Phase III Study Suggests

›
In continuation of my update on lenalidomide ... Data from the first large U.S. study assessing the effectiveness of long-term "...
Saturday, December 17, 2011

Drug combination highly effective for newly diagnosed myeloma patients......

›
A three-drug combination treatment for the blood cancer multiple myeloma compares favorably to the best established therapy for newly dia...
Tuesday, June 1, 2010

Promising treatment for aggressive lymphoma identified in new study

›
In continuation of my update on Lenalidomide ... I found this info interesting to share with... Promising treatment for aggressive lymphoma...
Tuesday, December 22, 2009

New three-drug combination for multiple myeloma ! ...

›
The regimen, known as RVD , combined the drugs Revlimid - ( lenalidomide ), Velcade - ( bortezomib ) and dexamethasone , which previously we...